acrylamide/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on type 2 diabetes incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Acrylamide intake was positively associated with the incidence of T2D in model 1 (P for trend = 0.009); however, our results showed no association in model 2 after adjusting for confounding variables.”
Quoted verbatim from The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.. - Study
- cohort
- Population
- 6022 adults (2707 men, 3315 women) free of diabetes at baseline in the Tehran Lipid and Glucose Study, dietary acrylamide intake by quartile, median follow-up 6.63 years; whole-cohort result
The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.2023PMID:37217800Permalink
Keep reading
- Everything the graph holds on acrylamide
- Every compound studied against Type 2 diabetes incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45T4AFXR0EWDG1AN6XZFECC